Clik here to view.
Bill Ackman just spent 4 hours defending his giant position in Valeant (VRX)
Billionaire activist investor Bill Ackman, founder of Pershing Square Capital, just wrapped up a four-hour long call defending his large investment in Valeant Pharmaceuticals."This is a complicated...
View ArticleClik here to view.
The SEC may have to return millions to a hedge fund it helped shut down
A hedge fund that paid the Securities and Exchange Commission a fine to avoid prosecution over insider trading charges may try and reclaim those funds after the conviction of its co-founder was...
View ArticleClik here to view.
SolarCity is getting nuked (SCTY)
SolarCity shares are tanking in morning trading on Friday after the company reported earnings Thursday.SolarCity's share price dropped by as much as 24% to the lowest levels in more than two years.The...
View ArticleClik here to view.
Bill Ackman wants us to remember how a young Warren Buffett took advantage of...
Bill Ackman wants people to remember salad oil. In a conference call on Friday defending his stake in Canadian pharmaceutical company Valeant, Ackman recalled an opportunity found by a then-35-year-old...
View ArticleClik here to view.
The short seller going after Valeant says he has more dirt on the company
Citron Research, the California-based short-selling research firm led by Andrew Left, tweeted on Friday that it was going to release an updated report on the embattled drug giant Valeant on Monday.The...
View ArticleClik here to view.
Here's Bill Ackman's full presentation defending his big Valeant bet (VRX)
Bill Ackman, the billionaire founder of Pershing Square Capital, spent nearly four hours hosting a call defending his massive investment in Valeant Pharmaceuticals.Ackman has lost more than $1 billion...
View ArticleClik here to view.
VALEANT SHORT SELLER: My new report won't have 'anything earth-shattering'
Citron Research founder Andrew Left, the short-seller targeting Valeant Pharmaceuticals, told the Wall Street Journal that his new report scheduled to come out Monday doesn't have "anything...
View ArticleClik here to view.
Hedge funds are behind the campaign to get Britain out of Europe
Some of the wealthiest individuals, financial institutions, and hedge funds are funding the attempt to persuade Britain to vote to leave the European Union.The Financial Times reports that hedge fund...
View ArticleClik here to view.
VALEANT SHORT SELLER: 'Our work here is done'
California-based short-selling firm Citron Research has released its updated report on Valeant Pharmaceuticals."Our work is done here," the six-page report said."We are looking forward to moving on to...
View ArticleClik here to view.
The short seller targeting Valeant used a full page of his new report to rip...
Short seller Andrew Left slammed hedge fund manager Bill Ackman in his latest report on the embattled drug company Valeant Pharmaceuticals.Ackman and Left are on opposite sides of a debate over...
View ArticleClik here to view.
DAN LOEB: These 5 fears have 'overwhelmed' the market
Activist investor Daniel Loeb, the founder of Third Point, laid out five fears that have "overwhelmed" the market in his third-quarter investor letter:"A weakening China, where the new question is not...
View ArticleClik here to view.
Bill Ackman's fund is down 19% this year after Valeant cratered
Pershing Square Holdings, the publicly traded vehicle led by hedge fund titan Bill Ackman, is down 19% year to date, according to a performance update.The fund fell 7.3% in October.Ackman had gone into...
View ArticleClik here to view.
PAUL SINGER: Everything in the market is more dangerous than it used to be
Paul Singer, the billionaire founder of $27 billion hedge fund Elliott Management, went off on the structure of financial markets in his fund's latest letter.Technology and financial engineering have...
View ArticleClik here to view.
Dan Loeb is out of the red
Activist investor Daniel Loeb, the founder of Third Point LLC, is out of the red. Third Point is flat through October 31, according to a performance update seen by Business Insider. During October,...
View ArticleClik here to view.
Herbalife earnings beat, but the stock is sliding (HLF)
For the third quarter, Herbalife, a multilevel marketing company that sells weightloss shakes, reported adjusted EPS of $1.28 versus analyst estimates of $1.05. Net sales for the third quarter came in...
View ArticleClik here to view.
Hedge fund legend Stan Druckenmiller raved about Amazon, one of his newest...
Legendary hedge fund manager Stanley Druckenmiller says he loves Amazon because, unlike IBM, it's not focused on short-term quarterly earnings. "The last 19 quarters, Amazon has missed their quarterly...
View ArticleClik here to view.
A letter gives a rare glimpse into one of the world's most secretive — and...
There are two types of investing, according to the departing partner of hugely successful and secretive hedge fund Baupost Group: "needle in a haystack investing" and "tide comes in and tide goes out...
View ArticleClik here to view.
Hedge fund manager Barry Rosenstein ditched Valeant's stock before its epic...
Activist investor Barry Rosenstein ditched his entire stake in Valeant Pharmaceuticals right before the shares plunged.The drugmaker's shares had been a big performance driver for Rosenstein's Jana...
View ArticleClik here to view.
Bill Ackman sent Valeant's CEO an intense email the day after the company's...
The Wall Street Journal's Monica Langley has a terrific behind-the-scenes account of Bill Ackman's exchanges with executives at the embattled pharma giant Valeant Pharmaceuticals.Ackman, founder of...
View ArticleClik here to view.
Here's the email Bill Ackman just sent the CEO of Valeant, after the...
Bill Ackman sent an email to J. Michael Pearson, the CEO of embattled drug company Valeant Pharmaceuticals, showing his support for the executive after The Wall Street Journal reported that Ackman had...
View Article